Investment offers
Stock Portfolio

The companies we include in our portfolio are selected after a thorough audit. This is made possible through our partnership with the auditing firm Van Cauter & Co, established in the Grand Duchy of Luxembourg for 25 years, at the heart of European finance. Their expertise allows us to reliably assess the companies in which we offer investments. We target companies operating in the sectors of new technologies, carbon capture and storage (CCS), carbon capture and utilization (CCU), and finance.

Our portfolio companies are spread over the following sectors:

Biotechnology

Volume of shares available:

US$ 294,318,045.4

Earnings per share

Average. Learn More

Our target are Startups with high potential. Ex: We collaborated with a startup that developed active eye implants against cataracts. developing the biotechnological materials of the future.
Interested, let us know here.

Pharmaceutical

Volume of shares available:

US$ 410,227,416.6

Earnings per share

Average. Learn more.

Our target are pharmaceutical companies with active ingredients in phase III clinical studies. Ex: we collaborate with a pharmaceutical laboratory that has developed an active antiviral against "Corona" type viruses. Interested, let us know here.

Electronic

Volume of shares available:

Undetermined

Earnings per share

Average. Learn more.

Of course, we invest in the classics, namely the manufacturers of electronic chips, with, however, a targeting of those who develop chips of the order of a nanometer.

Interested, let us know here.

Energy

Volume of shares available:

Undetermined

Earnings per share

Average. Learn more.

We target companies operating the energy transition, especially on the American market. and companies specializing in Carbon capture with permanent storage (CCS), Carbon capture with utilization (CCU) technologies. Interested, let us know here.

Investment offers Stock Portfolio

Investment offers
Stock Portfolio